E. Mendez-Alvarez

发表

Quantitative Determination of Uric Acid in Serum by Reversed-Phase Liquid Chromatography Using an Internal Standard

G. Sierra-marcuňo, R. Soto-Otero, E. Mendez-Alvarez, 1986 .

Assessment of oxidative stress markers in elderly patients with SARS-CoV-2 infection and potential prognostic implications in the medium and long term

Néstor Vázquez-Agra, Ana-Teresa Marques-Afonso, Antón Cruces-Sande, 2022, PloS one.

Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism

J. Labandeira-Garcia, A. Muñoz, M. Guerra, 2006, Neuropharmacology.

Angiotensin‐converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6‐hydroxydopamine rat model of Parkinsonism

J. Labandeira-Garcia, R. Soto-Otero, P. Rey, 2005, Journal of neuroscience research.

Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.

O. Nicolotti, Domenico Gadaleta, M. Catto, 2013, European journal of medicinal chemistry.

Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives.

B. Testa, F. Leonetti, M. Catto, 2007, Journal of medicinal chemistry.

Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.

Angelo Carotti, Francesco Leonetti, Orazio Nicolotti, 2006, Journal of medicinal chemistry.

A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.

Lourdes Santana, Humberto González-Díaz, Eugenio Uriarte, 2006, Journal of medicinal chemistry.

Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B i

C. Caccia, F. Leonetti, O. Nicolotti, 2009, Journal of medicinal chemistry.

8‐Aminomethyl‐7‐hydroxy‐4‐methylcoumarins as Multitarget Leads for Alzheimer's Disease

F. Sussman, J. Brea, M. Catto, 2016 .

Searching for Multi-Targeting Neurotherapeutics against Alzheimer’s: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif

N. Denora, G. Mangiatordi, O. Nicolotti, 2016, Molecules.

Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions

Á. Hermida-Ameijeiras, S. Sánchez-Iglesias, R. Soto-Otero, 2004, Neurochemistry International.

Effect of iron and manganese on hydroxyl radical production by 6-hydroxydopamine: mediation of antioxidants.

J. Labandeira-Garcia, Á. Hermida-Ameijeiras, R. Soto-Otero, 2001, Free radical biology & medicine.

2‐Benzazepine Nitrones Protect Dopaminergic Neurons against 6‐Hydroxydopamine‐Induced Oxidative Toxicity

A. V. Varlamov, V. P. Zaytsev, M. de Candia, 2012, Archiv der Pharmazie.

Ester derivatives of annulated tetrahydroazocines: a new class of selective acetylcholinesterase inhibitors.

A. V. Varlamov, M. de Candia, M. Catto, 2006, Bioorganic & medicinal chemistry.

Autoxidation and Neurotoxicity of 6‐Hydroxydopamine in the Presence of Some Antioxidants

J. Labandeira-Garcia, Á. Hermida-Ameijeiras, R. Soto-Otero, 2000, Journal of neurochemistry.

Copper Increases Brain Oxidative Stress and Enhances the Ability of 6-Hydroxydopamine to Cause Dopaminergic Degeneration in a Rat Model of Parkinson’s Disease

P. Bermejo-Barrera, A. Rodriguez-Perez, J. Labandeira-Garcia, 2018, Molecular Neurobiology.

Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants.

R. Soto-Otero, I. Sánchez-Sellero, E. Mendez-Alvarez, 2011, Journal of pharmacological and toxicological methods.

Study on the ability of 1,2,3,4‐tetrahydropapaveroline to cause oxidative stress: Mechanisms and potential implications in relation to parkinson's disease

Á. Hermida-Ameijeiras, S. Sánchez-Iglesias, R. Soto-Otero, 2006, Journal of biochemical and molecular toxicology.

Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6‐OHDA‐induced model of Parkinson’s disease

J. Labandeira-Garcia, S. Sánchez-Iglesias, J. Iglesias-González, 2009, Journal of neurochemistry.

Analysis of brain regional distribution of aluminium in rats via oral and intraperitoneal administration.

M. Barciela-Alonso, P. Bermejo-Barrera, S. Sánchez-Iglesias, 2007, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

In vitro inhibition of catalase activity by cigarette smoke: relevance for oxidative stress

E. Mendez-Alvarez, R. Soto-Otero, I. Sánchez-Sellero, 1998, Journal of applied toxicology : JAT.

Effects of Aluminium on Rat Brain Mitochondria Bioenergetics: an In vitro and In vivo Study

A. Beiras-Iglesias, S. Sánchez-Iglesias, J. Iglesias-González, 2015, Molecular Neurobiology.

Simultaneous Determination of Ethosuximide, Phenobarbital, Pheny-Toin, and Carbamazepine in Brain Tissue by HPLC

G. Sierra-marcuňo, R. Soto-Otero, E. Mendez-Alvarez, 1985 .

Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6'-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors.

O. Nicolotti, M. Catto, A. Carotti, 2013, Journal of medicinal chemistry.

Copper increases the ability of 6‐hydroxydopamine to generate oxidative stress and the ability of ascorbate and glutathione to potentiate this effect: potential implications in Parkinson's disease

R. Soto-Otero, A. Cruces-Sande, E. Mendez-Alvarez, 2017, Journal of neurochemistry.

Inhibition of 6-hydroxydopamine-induced oxidative damage by 4,5-dihydro-3H-2-benzazepine N-oxides.

M. de Candia, F. Zubkov, C. Altomare, 2008, Biochemical pharmacology.

Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease.

Ramón Soto-Otero, Estefanía Méndez-Alvarez, J. Labandeira-Garcia, 2002, Biochemical pharmacology.

Experimental spike-and-wave discharges induced by pentylenetetrazol and tolerance to repeated injections: an electrophysiological and biochemical study

G. Sierra-Paredes, G. Sierra-marcuňo, R. Soto-Otero, 1989, Epilepsy Research.

Implications of Inflammatory and Oxidative Stress Markers in the Attenuation of Nocturnal Blood Pressure Dipping

A. González-Quintela, Néstor Vázquez-Agra, Antón Cruces-Sande, 2023, Journal of clinical medicine.

Studies on the interaction between 1,2,3,4-tetrahydro-β-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease

R. Soto-Otero, I. Sánchez-Sellero, E. Méndez-Álvarez, 1998, Brain Research.

Correlation between Blunted Nocturnal Decrease in Diastolic Blood Pressure and Oxidative Stress: An Observational Study

Néstor Vázquez-Agra, Antón Cruces-Sande, J. López-Paz, 2022, Antioxidants.

Differential Toxicity of 6-Hydroxydopamine in SH-SY5Y Human Neuroblastoma Cells and Rat Brain Mitochondria: Protective Role of Catalase and Superoxide Dismutase

P. Jenner, S. Rose, S. Sánchez-Iglesias, 2012, Neurochemical Research.

Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease.

J. Labandeira-Garcia, Á. Hermida-Ameijeiras, R. Soto-Otero, 2002, Biochimica et biophysica acta.

Time-Course of Brain Oxidative Damage Caused by Intrastriatal Administration of 6-Hydroxydopamine in a Rat Model of Parkinson’s Disease

J. Labandeira-Garcia, S. Sánchez-Iglesias, R. Soto-Otero, 2006, Neurochemical Research.

Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases.

P. Carrupt, Alessandra Nurisso, N. Denora, 2015, Journal of medicinal chemistry.

Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers

Ana-Teresa Marques-Afonso, J. López-Paz, A. Pose-Reino, 2023, Antioxidants.

Differential Toxicity of 6-Hydroxydopamine in SH-SY5Y Human Neuroblastoma Cells and Rat Brain Mitochondria: Protective Role of Catalase and Superoxide Dismutase

P. Jenner, S. Rose, S. Sánchez-Iglesias, 2012, Neurochemical Research.

A simple method for isolating rat brain mitochondria with high metabolic activity: Effects of EDTA and EGTA

A. Beiras-Iglesias, S. Sánchez-Iglesias, J. Iglesias-González, 2013, Journal of Neuroscience Methods.

In vitro inhibition of catalase activity by cigarette smoke: relevance for oxidative stress

R. Soto-Otero, I. Sánchez-Sellero, M. López-Rivadulla Lamas, 1998, Journal of applied toxicology : JAT.

In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors.

Angelo Carotti, Orazio Nicolotti, Domenico Gadaleta, 2015, European journal of medicinal chemistry.

Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke.

E Méndez-Alvarez, R Soto-Otero, I Sánchez-Sellero, 1997, Life Science.